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Estimating prognosis in patients 
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Hao Gao 1, Kenneth Mangion 2,3, David Carrick2,3, Dirk Husmeier 1, Xiaoyu Luo  1 &  
Colin Berry 2,3
Biomechanical computational models have potential prognostic utility in patients after an acute ST-
segment–elevation myocardial infarction (STEMI). In a proof-of-concept study, we defined two groups 
(1) an acute STEMI group (n = 6, 83% male, age 54 ± 12 years) complicated by left ventricular (LV) 
systolic dysfunction; (2) an age- and sex- matched hyper-control group (n = 6, 83% male, age 46 ± 14 
years), no prior history of cardiovascular disease and normal systolic blood pressure (SBP < 130 mmHg). 
Cardiac MRI was performed in the patients (2 days & 6 months post-STEMI) and the volunteers, and 
biomechanical heart models were synthesized for each subject. The candidate parameters included 
normalized active tension (ATnorm) and active tension at the resting sarcomere length (Treq, reflecting 
required contractility). Myocardial contractility was inversely determined from personalized heart 
models by matching CMR-imaged LV dynamics. Compared with controls, patients with recent STEMI 
exhibited increased LV wall active tension when normalized by SBP. We observed a linear relationship 
between Treq 2 days post-MI and global longitudinal strain 6 months later (r = 0.86; p = 0.03). Treq may 
be associated with changes in LV function in the longer term in STEMI patients complicated by LV 
dysfunction. Further studies seem warranted.
Death rates after acute ST-segment–elevation myocardial infarction (STEMI) have fallen markedly in recent 
years1, but the incidence of heart failure post-MI has remained persistently high2, and heart failure remains one 
of the most important causes of death post-MI3. Adverse left ventricular remodelling after acute MI portends an 
increased risk of heart failure4,5, based on the pathophysiology of impaired left ventricular systolic function6,7, 
infarct size8 and microvascular pathology9,10. Approximately one half of all patients who survive a STEMI have 
persistent, irreversible myocardial damage that is associated with a longer-term risk of heart failure9,10.
In clinical practice, therapeutic decisions are informed by an evidence base linked to surrogate biomarkers, 
notably left ventricular ejection fraction (LVEF)1. On the other hand, LVEF reflects changes in left ventricular 
dimensions during the cardiac cycle, rather than contractility (pump function), and the majority of patients who 
die prematurely have a normal or mildly reduced LVEF11. Therefore, on an individual patient basis, risk predic-
tion using LVEF remains somewhat limited. Advances in myocardial strain imaging hold promise12. Clinicians 
usually lack information on left ventricular biomechanics in their patients after an acute STEMI, but even if 
biomechanics were described, their clinical significance in this setting is unknown. Personalized computational 
heart modelling have emerging potential to quantitatively assess biomechanical parameters which directly reflect 
left ventricular pump function13,14.
Biomechanical heart models have advanced from idealized theoretical concepts to subject-specific models 
with multi-scale i.e. intra-cellular, whole cell, inter-cellular tissue, organ, and multi-physics e.g. electrophysiology, 
myocardial biomechanics, blood flow, coupling under physiological and pathological conditions14–16, including 
post-MI17,18. Biomechanical models that are based on cardiac magnetic resonance (CMR) imaging, although 
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complex and time-intensive, have potential to realise computational heart modelling for personalized risk pre-
diction in the clinic13.
We designated candidate biomechanical parameters implicated in left ventricular pump function including 
AT nor  which is the normalized active tension (AT) in the left ventricular wall,  defined as 
=AT AT /(Systolic Blood Pressure)nor . AT nor reflects the active left ventricular tension associated with a 1 mmHg 
increase in systolic blood pressure (BP). We also focused on T req which is the active myocyte tension at the resting 
sarcomere length when myocyte stretch is 1, which reflects the required contractility at that moment. T req  is 
therefore a parameter of global biomechanical function. We hypothesized that these novel biomechanical param-
eters would be (1) more discriminative for the assessment of individual patients with acute STEMI compared to 
healthy controls matched for age, and sex and, (2) potentially have greater prognostic significance for left ven-
tricular function in the longer term. Our hypothesis was that these biomechanical parameters more closely reflect 
contractility and left ventricular pump performance than standard global measures, such as LVEF, and therefore 
would be discriminative.
There is a knowledge gap on the clinical significance of biomechanical parameters in patients following an 
acute STEMI. We aimed to investigate the discriminative value of candidate biomechanical indices estimated 
by computational heart modelling in patients with acute STEMI and healthy control subjects matched for age 
and sex. Left ventricular biomechanics in vivo were assessed using an immersed boundary-finite element (IB/
FE) method incorporating data on myocardial function and infarct characteristics from the CMR scans obtained 
from patients with acute severe STEMI and healthy controls without any history of cardiovascular disease.
Results
The characteristics of the study participants, including their CMR findings, are described in Table 1 and in the 
Supplement. The patients with acute STEMI had evidence of extensive infarction (40.5 ± 7.8% left ventricular 
mass) and microvascular obstruction (8.3 ± 4.5% left ventricular mass), as revealed by contrast-enhanced CMR. 
The mean LVEF was moderately reduced (41 ± 5%).
Table 2 summarizes left ventricular cavity volume and strain difference between the simulated values from per-
sonalized Left ventricular models and the in vivo CMR measurements. The relative difference of LV end-diastolic 
volume (LVEDV) in both the hyper-control group and the STEMI group were within in 2%. Systolic circumfer-
ential strain difference in the hyper-control group was slightly higher than the STEMI group, which was because 
the objective function in the hyper-control group incorporated left ventricular end-systolic volume (Eq. (8)). 
Figure 1 shows an example of systolic circumferential strains from a simulated left ventricular model after per-
sonalization, which matched well with the CMR measurements. In Fig. 2A and B, the simulated left ventricular 
geometries from one healthy control subject at end-diastole and end-systole are shown with superimposed CMR 
images. Similarly, the results from a patient are shown in Fig. 2C and D. The simulated left ventricular geometries 
agreed well with the CMR images.
The biomechanical parameters, myocardial active tension (σa) and required myocardial contractility (T req), 
were normally distributed. The average T req in the hyper-control group and the STEMI group is shown in Fig. 3. 
T req in the hyper-control group was 144 ± 15 kPa, which was lower than the value of the STEMI group ((166 ± 18 
kPa; p = 0.04), as shown in Fig. 3A. Compared with the hyper-control group, σa was slightly higher in the STEMI 
Hyper-control STEMI p-value
Characteristics
Age, years 46 ± 14 54 ± 12 0.3
Sex, male: female 5:1 5:1 1.0
Systolic blood pressure, 
mmHg 129 ± 13 114 ± 14 0.09
Diastolic blood 
pressure, mmHg 74 ± 14 74 ± 13 1.0
Cardiac magnetic resonance
LV EDV, mL 121 ± 12 146.6 ± 27 0.06
LV ESV, mL 52 ± 10 96.1 ± 21.3  < 0.01
LVEF, % 57 ± 6 41 ± 5  < 0.01
GLS, % −20.0 ± 5 −10.2 ± 3.2  < 0.01
Infarct size, % LV mass ~ 40.5 ± 7.8
Microvascular 
obstruction, n % 6 (100)
Microvascular 
obstruction, % LV mass 8.3 ± 4.5
Table 1. Patient characteristics. EDV: end-diastolic volume (ml), ESV: end-systolic volume (ml), LV: left 
ventricular, LVEF: left ventricular ejection fraction (%), SBP: systolic blood pressure (cuff-measured) mmHg; 
GLS: global longitudinal strain; Infarct size is defined as a percentage of left ventricular mass. p values are 
reported using the student t-test by comparing the control groups to the STEMI group. Values are presented 
as mean ± standard deviation unless otherwise stated. *Detailed characteristics for the STEMI patients are 
provided in Supplementary Table S1.
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group (65 ± 9 kPa vs. 57 ± 4kPa; p = 0.08), as shown in Fig. 3B. Figure 3C compares the normalized active tension 
(AT nor), which was defined as σa/systolic BP, were significantly lower in the control groups compared to the value 
in the STEMI group (0.43 ± 0.04 vs. 0.57 ± 0.06; p < 0.01). This difference may indicate that following an acute 
STEMI, higher active tension was necessary to maintain normal left ventricular pump function to compensate the 
loss of functional myocardium in MI region.
Since direct invasive measures of LVEDP were not available, these data were assumed based on typical ref-
erence values. We further increased LVEDP to be 15 mmHg in a healthy subject in order to estimate how dif-
ferent LVEDP values affect left ventricular systolic contraction. The estimated myofibre passive stiffness with 
15 mmHg LVEDP was much higher compared to the estimated stiffness with 8 mmHg, as shown in Fig. 4. On 
the contrary, left ventricular systolic function was not affected much after rerunning the model following the 
personalization procedure. We found that T req was decreased by 4%, while σa and AT nor were nearly the same, 
with a mean difference of 0.5%. Therefore, T req, σa and AT nor were overly not sensitive to changes in LVEDP if 
the left ventricular model matches volume and deformation at end-diastole. Indeed, similar findings were 
reported by Sun et al.19.
Clinical correlates of the biomechanical parameters at baseline. In all healthy controls, only T req 
was weakly related to weight and systolic BP (summarized in Supplement Table S2), but not related to age, height 
ED volume 
difference (%)
ES volume 
difference (%)
Systolic strain 
difference (%)
Hyper-control 1.3 ± 1.3 2.2 ± 1.6 6.5 ± 5.1
STEMI 0.8 ± 0.7 1.1 ± 0.4
Table 2. Optimization results in the hyper-control group and the STEMI group. Volume difference was defined 
as ∑ ×=
| − |( 100%)/6i
V V
V1
6 i i
i
measured
measured
, and V is the simulated LV cavity volume, V measured is the measured value; strain 
difference was defined as ∑ | | ×ε ε
ε=
−¯ ¯
¯
( 100%)/6i 1
6 i i
i
measured
measured
, and εi is the average systolic strain in one subject, which 
is ε ε= ∑ N( )/i iN i , in which N is the total segmental number.
Figure 1. Predicted systolic strain from a personalized left ventricular model compared with in vivo 
measurements in one healthy subject.
Figure 2. Simulated left ventricular dynamics in a healthy control subject and a patient after acute STEMI. 
(A,B) Deformed left ventricular geometries superimposed in CMR images at end-diastole and end-systole for 
the healthy control and for the MI patient (C,D). (A–D) are coloured by displacements related to the early-
diastole geometry. Red: high, blue: low.
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and sex. In the STEMI group, we observed associations between σa and systolic BP, height, between AT nor and 
LVEF. We did not observe associations between T req, σa, AT nor and age, weight, sex, measured biochemical bio-
markers including peak troponin I, C-reactive protein, and duration of symptoms (ischemic time) in the patient 
group at baseline.
Associations between biomechanical parameters at baseline and left ventricular function at 6 
months. Table 3 summarizes the correlations between the LVEF, global longitudinal strain (GLS), T req, σa and 
Figure 3. Comparisons between the control groups and the STEMI group in: (A), required contractility;  
(B) average systolic active tention; (C), systolic blood pressure; and (D), active tension generation per mmHg 
ventricular pressure increase.
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AT nor at baseline and left ventricular function at 6 months in the STEMI group. We observed a strong linear 
relationship between T req estimated 2 days post-STEMI and GLS at six months (r = 0.86; p = 0.03), as shown in 
Fig. 5A. This result indicates that a lower T req after an acute STEMI complicated with no-reflow could have prog-
nostic value for prediction of the recovery in left ventricular pump function (greater GLS) in the longer term. 
Figure 5B shows the relationship for change in LVEF (%) at six months from baseline after the acute STEMI and 
T req. We observed a weak negative correlation between T req and changes in LVEF over time (r = −0.44, p = 0.38), 
however, the result was not statistically significant.
Discussion
In this study, we modelled left ventricular dynamics at end-diastole and end-systole in patients following acute 
severe STEMI complicated by no-reflow and in healthy controls. The computational left ventricular models were 
exclusively based on in vivo CMR data along with detailed models of active myocardial tension generation. For 
the first time, we have shown that, compared with the hyper-control group, patients with recent STEMI compli-
cated by left ventricular systolic dysfunction, exhibited increased active tension generation. The biomechanical 
parameters, required contractility (T req) and normalized active tension (AT nor), were distinctly different between 
patients and controls. Furthermore, we have found preliminary evidence that these parameters may have prog-
nostic value for left ventricular function at 6 months, whereas LVEF and global longitudinal strain did not (pre-
sumably reflecting the lower magnitude of correlation and the limited sample size of selected patients with relative 
large infarct size and left ventricular dysfunction). We have provided proof-of-concept insights into the potential 
clinical relevance of novel biomechanical parameters (T req and AT nor) of left ventricular pump function.
Most computational heart modelling nowadays is based on nonlinear soft tissue mechanics using finite ele-
ment methods15. In this study, an immersed boundary approach was employed, which has been used extensively 
to model cardiac dynamics and valves accounting for blood-tissue interaction since its introduce in 1970s20. 
In recent years, the authors’ group has further developed a hybrid immersed boundary method to study left 
ventricular dynamics, which agreed well with in vivo CMR measurements18, commercial FEM packages21, and 
validated with other modelling approaches22.
To estimate passive material property, a population based LVEDP was assumed for the hyper-control group 
and the STEMI group based on the fact that LVEDP is generally higher in MI patients (10–25 mmHg) compared 
to healthy subjects (5–10 mmHg)23 as in our previous study18. In our model, myocardial systolic function T req and 
Figure 4. Estimated stiffness along myofibre direction under differnet end-diastolic pressure.
Baseline Coefficient
Change in LVEF after six months Global longitudinal strain after six months
95% confidence 
interval p-value Coefficient
95% confidence 
interval p-value
LVEF, % −0.65 [−0.96 0.33] 0.16 0.59 [−0.42 0.95] 0.22
GLS, % −0.21 [−0.87 0.73] 0.70 0.42 [−0.59 0.92] 0.41
Required contractility 
(T req), kPa −0.44 [−0.92 0.58] 0.38 0.86 [0.17 0.98] 0.03
Active tension (σa), 
kPa 0.76 [−0.14 0.97] 0.08 −0.40 [−0.91 0.61] 0.43
Normalized Active 
tension (AT nor), kPa/
mmHg
0.79 [−0.06 0.98] 0.06 −0.69 [−0.96 0.28] 0.13
Table 3. Standard and novel biomechanical parameters early post-MI, and their relationships with LV systolic 
function at 6 months. The normality test was performed by the One-Sample Kolmogorov-Smirnov Test, except 
for change in left ventricular ejection fraction (LVEF) at baseline, GLS, T req, σa, AT nor at baseline and global 
longitudinal strain (GLS) at six months followed standard normal distributions, therefore, Pearson’s correlation 
analysis was adopted for the correlation analysis.
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AT nor are not explicitly depended on passive parameters, but through ED volume, systolic circumferential strain 
and pressure. Therefore, the matched LVEDV and deformation at end-diastole helps to reduce the effects on sys-
tolic function caused by different ED pressures. Other studies19 also have shown that variations in passive param-
eters had little effects on estimated myocardial contractility. Therefore, the assumed LVEDP will not affect our 
conclusion on myocardial contractile function much in this study. However, myocardial passive stiffness is highly 
depended on the ED pressure, as shown in Fig. 4. Therefore, caution needs to be paid when comparing myocar-
dial stiffness between the healthy controls and the MI patients because a higher LVEDP will indicate higher pas-
sive stiffness24. Future studies shall use measured LVEDP whenever possible so that diastolic left ventricular 
mechanics can be investigated more accurately and reliably.
Regional circumferential strains from cine images were estimated using in-house developed b-spline deform-
able registration method25 (Figure S1 in the supplementary material), in which segmentation of left ventricular 
wall boundaries and region definitions at end-diastole are the only user inputs. This approach was initially com-
pared with Displacement Encoding with Stimulated Echoes (DENSE)26 in a small number of healthy volunteers 
and MI patients25, and validated within a large cohort of healthy volunteers27 recently. In this study, we further 
performed a reproducibility study (intra-/inter-observer variability) six months later. Details are provided in 
the supplement. In the healthy group, the relative mean bias was 0.4 ± 6.5% for intra-observer, and 0.3 ± 8.1% 
for inter-observer. Similar results were found in the MI group. The inter-correlation coefficient was > 0.93 for 
Figure 5. The scatter plots of (A): the global longitudinal strain (GLS) and (B): LVEF change after six months in 
the STEMI group in related to the required contractility.
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all analysis. This is consistent with findings from the study by Mangion et al.27, in which they demonstrated that 
cine-estimated circumferential strain using this b-spline deformable registration method has similar diagnos-
tic performance as DENSE within healthy individuals, and more reproducible than feature tracking27. Similar 
as in other strain estimation techniques using MR imaging, the overall accuracy of our cine strain estimation 
approaches would be affected by imaging quality, out-of-plane motion, respiratory motion, etc.28.
In systolic phase, only T req was inversely determined, while other parameters of the active contraction models 
were fixed. The same approach has been widely used in many other studies16,17,19,29–31 to model in vivo ventricular 
function, but avoid to determining many different parameters at cellular level, which is nearly impossible from in 
vivo CMR imaging. To evaluate how sensitive the modelled left ventricular contractile function was to uncertain-
ties in strain measurements, simulations were rerun by varying measured strains with 10% change (subtracting 
0.015 in magnitude). We found that a 10% decrease in average systolic circumferential strain would result in 20% 
decrease in optimized T req, however, the difference in AT nor is less than 1%. This much higher sensitivity in T req 
was not surprising because systolic circumferential strain is a key function reflecting myocardial contractility32, 
as reported by Sun et al.19. As discussed above, strain estimation from cine images has high reproducibility with 
nearly zero bias in intra-/inter observer variability in both the healthy and MI groups, and similar diagnostic 
performance as in DENSE25,27, and is well within the reported ranges from other studies27,33–35. Moreover, T req is 
determined by multiple strain data (Eqs 8 and 9) and is further constrained by a matched end-systolic volume in 
healthy subjects (Eq. 8). Therefore, we believe in this ‘extreme-case’–‘hyper-control’ study, uncertainties in circum-
ferential strain estimation using cine images will not affect our findings on T req and AT nor. However, further 
studies are required to investigate how T req and AT nor would be affected by various uncertainties within unse-
lected patients, such as NSTEMI patients. Needless to say, accurate measurements (3D MR imaging) and access 
to a rich dataset (voxel-wise motion/strain data) are essential to further improve the credibility of cardiac models. 
Indeed, though not routinely available, 3D MR imaging are begun to be used in left ventricular modelling16,36.
Our results on myocardial contractile function after acute MI are consistent with prior mathematical model-
ling of animal and human hearts, in which myocardial contractility was shown to paradoxically increase in dis-
eased hearts, potentially reflecting a compensatory response18,36. Chabiniok et al.37 found that in a pig model of 
reperfused MI, the estimated contractility in the remote zones increased progressively up to one-month later. We 
found that left ventricular contractility directly reflected by T req in the group of STEMI patients was higher com-
pared to the hyper-control group. Harding et al.38 found that the maximum myocardial contractility was not 
reduced in cardiomyocytes obtained from failing hearts compared to non-failing control hearts, rather reduced 
beta-adrenoceptor sensitivity was the distinguishing functional problem associated with clinical heart failure and 
increasing with age. Houser and Margulies39 further confirmed that the basal contractility was well preserved 
under resting conditions in dysfunctional hearts, but the ability to increase contractility (contractility reserve) in 
response to inotropic stimuli was severely depressed. The enhanced overall left ventricular contractility in the 
STEMI patients compared to controls in our study may be explained by adaptive mechanisms6,40, such as 
sympatho-adrenal and neurohumoral mechanisms, in order to preserve left ventricular pump function and car-
diac output. Taken together, our results may provide insights into left ventricular biomechanics that complement 
the Frank-Starling law of the heart7. On the other hand, myocardial contractile reserve is finite and left ventricular 
remodelling in the longer term may have maladaptive consequences7. A cardiomyocyte with a lower T req may 
have innate capacity to augment contractility, as shown in Fig. 5, supporting the possibility of recovery in left 
ventricular systolic function post-MI in patients with lower T req.
We have shown that biomechanical parameters of left ventricular function may present new insights into the 
pathophysiology of acute MI over and above standard measures of left ventricular pump function (Table 3). Our 
case-control study was designed by including groups of patients with left ventricular systolic dysfunction with 
similarly severe impairments of pump function, the insights gained in this study may not be generally applicable 
to all MI patients. Further research is warranted in order to assess the prognostic performance of T req and AT nor 
compared with other established measures of prognosis, such as LVEF and left ventricular end-systolic volume, 
in larger and less selected patient cohorts. Should this be the case then T req and AT nor may represent therapeutic 
targets in clinical research e.g. as biomarkers of treatment effect in experimental and clinical studies of novel 
therapies to prevent adverse remodelling.
The AT nor was much lower in the hyper-control groups compared to the STEMI group. These results stimulate 
a new hypothesis based on biomechanics for the observed higher myocardial AT nor in patients with recent 
STEMI. We hypothesize that contractility may be augmented in remote myocardium to generate sufficient active 
tension and preserve left ventricular pump function. This homeostatic adaptation would serve to compensate for 
the loss of functioning myocytes within the infarct zone. The requirement for enhanced and sustained active 
tension generation in the MI patients could lead to loss of contractile reserve that in turn could lead to impaired 
left ventricular systolic function and heart failure in the longer term. A diagram of the proposed hypothesis is 
illustrated in the Supplement (Figure S2).
Validation and verification of mathematical modelling remains a grand challenge in the whole biomechanics 
modelling communities. It is also an essential step for the success of the clinical translation. Growing efforts are 
being made through comparisons to experimental benchmark data41, to clinical images19,42 and to different com-
putational models21,22. Directly measuring T req  and AT nor can be extremely difficult in vivo, even in vitro. 
Moreover, in vitro measurements can differ significantly from in vivo assessments. For example, much higher 
Ca2+ sensitivity and isometric tension were reported in ‘intact’ myocytes than in ‘skinned’ myocytes43. Indirect 
validation can be achieved by comparing modelling results with other computational models. Table 4 summaries 
required myocardial contractility from recent computational ventricular models derived from in vivo clinical 
data. Although there are variations among different studies, required contractility in the healthy group and the 
www.nature.com/scientificreports/
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STEMI group in our study are within the values reported by other studies. The variations might be due to 
inter-individual variations, sample size, different mathematical descriptions, etc. Furthermore, we also observed 
that estimated myocardial contractility is higher in diseased heart compared to healthy subjects (Table 4).
A comprehensive understanding of heart function includes physiology, pathology, biochemistry, biophysics, 
biomechanics, etc. One of the advantages of personalized mathematical models, such as the model that we have 
developed, has the potential to provide a unique way to understand quantitatively left ventricular pump function 
by integrating multiscale and multiphysics in one model44. LVEF and global longitudinal strain do not reflect 
contractile reserve (or effort) because these parameters are the final output of myocardial contraction, not the 
determinants of the contraction. However, the proposed biomechanical parameters (T req and AT nor) should not 
be considered as replacements of clinical indices, such as LVEF or global longitudinal strain. In this study, patients 
in the STEMI group had a relatively large size of infarction complicated by microvascular obstruction, thus, LVEF 
was enough to separate these individuals from healthy subjects, while biomechanical parameters, such as the T req, 
may further discriminated STEMI patients with similar LVEF as indicated in Fig. 5, a lower T req may suggest that 
those patients could have better recovery in the longer term, different treatments might be possible. This observa-
tion suggests that T req may provide additional incremental information above left ventricular pump function, and 
could potentially help the patient management. Well-designed experiments are needed to further explore the 
relationships between enhanced active tension and the loss of contractile reserve with measurements ranging 
from cellular contractility to tissue stress distribution, and their changes follow-up. Our proof-of-concept results 
are hypothesis generating and further studies of the associations between T req and AT nor with physiological and 
pathological biomarkers seem warranted.
Other limitations. The required contractility parameter reflects the whole of the left ventricle, and regional 
values were not calculated. Although the sample size was limited with selected patients, it was similar to other 
studies involving computational heart modelling. As such, the results are hypothesis generating. The prognostic 
results provide preliminary validation. Other limitations include: (1) the “extreme case” design, which helped 
reduce the number for identifying the difference, however, it was still not clear to which extent the proposed bio-
mechanical parameters can have prognostic values; (2) future work shall include different patient types, i.e. 
STEMI patients with preserved left ventricular function with/without ‘no-reflow’, and shall evaluate how biome-
chanical factors vary according to age and sex, and how they evolve after acute MI; (3) we only estimated the 
overall T req in the functional myocardium, but not considering regional contractile function in the “border zone” 
and MI regions; (4) we have not explored other factors (i.e. different MI characteristics, such as intra myocardial 
hemorhage) that are known to affect left ventricular pump function and its recovery.
Conclusion
In summary, we have simulated left ventricular dynamics using CMR imaging at end-diastole and end-systole for 
a group of patients with acute severe STEMI complicated by ‘no-reflow’ and an age-/sex-matched hyper-control 
group with normal blood pressure. Our results showed that the required contractility (T req) in the STEMI group 
was higher than the hyper-control group, and that similar results were observed for the systolic active tension and 
normalized active tension (AT nor). T req and AT nor were not overly sensitive to end-diastolic pressure if the left 
ventricular model can match end-diastolic volume and deformation. Furthermore, on an individual patient basis, 
the enhanced contractility demand may have negative consequences for left ventricular function and remodelling 
post-MI within those patients, who had acute left ventricular systolic dysfunction due to large myocardial infarc-
tion and extensive microvascular obstruction. The differences in required contractility and normalized active 
Studies Imaging modality Number of subjects Myocardial contractility
Genet et al.16 Tagged MRI 5 HVs 143 kPa
Genet et al.53 3D cine, 3D tagged, 2D LGE MRI 1 MI patient 146.9 kPa
Wenk, et al.17 Tagged and LGE MRI 1 MI patient 109.5 kPa
Wang et al.30 Cine MRI
6 HVs 88 kPa (HV)
5 hypertrophic HF 160 kPa (hypertrophic)
9 non-ischemic HF 124 kPa (NI- HF)
Gao et al.18 Cine MRI
1 HV 168.6 kPa (HV)
1 MI patient 309.1 kPa (MI)
Asner et al.36 Cine, 3D tagged, and 4D flow MRI 1 HV 139 kPa
Land et al.43 CT imaging 3 Patients with healthy heart function 120 kPa
Our study Cine MRI
6 HVs 144 kPa
6 STEMI patients 166 kPa
Table 4. Summary of estimated myocardial contractility from computational models of human hearts (Values 
for diseased hearts in bold fonts), HF: heart failure, MI: myocardial infarction, HV: healthy volunteer with 
normal cardiac function.
www.nature.com/scientificreports/
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tension between the healthy controls and the STEMI patients suggest that these novel biomechanical parameters 
may have clinical value for prognostication on an individual patient basis.
Methods
Study design. The UK Research Ethics Service (ethics committee references: 10/S0703/28 and 11/AL/0190) 
approved the study and all of the participants provided written informed consent. All methods, including MRI45, 
were performed in accordance with the relevant guidelines and regulations. Given the unknown validity of the 
parameters, and the potential to mistakenly reject (Type 1 error) or accept (Type 2 error) a true null hypothesis, 
we implemented an ‘extreme-case’ – ‘hyper-control’ design in a proof-of-concept study of the potential discrimi-
native value of novel biomechanical parameters46.
Study population: patients with acute STEMI. Patients were identified from the British Heart 
Foundation MR-MI study population (ClinicalTrials.gov identifier: NCT02072850). We identified six patients 
(extreme case group) with acute severe left ventricular dysfunction from a population of patients (n = 324) with 
acute STEMI who had been enrolled into a single centre prospective CMR cohort study between July 14, 2011 and 
November 22, 2012. Patients with acute STEMI were eligible for enrolment in this study if they had an indication 
for emergency PCI due to a history of symptoms consistent with acute myocardial ischemia and with supporting 
changes on the electrocardiogram (i.e. ST-segment elevation or new left bundle-branch block). Exclusion criteria 
represented standard contra-indications to contrast CMR, including a pacemaker and estimated glomerular fil-
tration rate <30 ml/min/1.73 m2.
For extreme cases, we selected STEMI patients with acute severe left ventricular dysfunction due to 
“no-reflow”, which is a severe form of acute reperfusion injury47. “No-reflow”, which is defined as an acute 
reduction in myocardial blood flow despite a patent epicardial coronary artery, is independently associated with 
adverse remodelling and adverse outcome48.
Control groups. We used community adverts and personal contacts to invite healthy volunteers to partici-
pate in an imaging study. We enrolled adults with no prior history of cardiovascular disease or treatment in whom 
cardiac disease was excluded based on a normal electrocardiogram (ECG) and a normal CMR scan. Six healthy 
volunteers were selected as the hyper-control group with normal office blood pressure (<130/80 mmHg) at the 
time of the scan per ESC Guidelines for the management of arterial hypertension49. The hyper-control group 
matched the acute STEMI group in age and sex.
Measurement of blood pressure. Blood pressure (BP) was measured according to standard guidelines50. 
Subjects were invited to rest for ten or more minutes prior to the BP measurement. Two arm-cuff BP measure-
ments were obtained in the sitting position at least 5 minutes apart. The standard size cuff was used and a larger or 
smaller bladder was used for large or thin arms, respectively. The cuff was placed at the level of the heart. We used 
auscultation of phase I and V (disappearance) Korotkoff sounds to identify systolic and diastolic BP, respectively.
CMR imaging. CMR was performed at 1.5 Tesla (Siemens Avanto, Siemens Healthcare, Erlangen, Germany) 
in the six patients with acute STEMI 2 days after hospital admission and six months later. CMR was also per-
formed in the healthy volunteers. Patients and healthy volunteers underwent the same imaging protocol except 
that healthy volunteers <45 years did not receive intravenous gadolinium contrast.
The CMR protocol for imaging left ventricular structure and functional assessment involved steady-state free 
precession cine scans with a short-axis left ventricular stack from the base to the apex. The slice thickness was 
7 mm with 3mm gap, typical cine imaging parameters were matrix = 180 × 256, flip angle = 80°, TR: 3.3 ms, 
TE: 1.2ms, bandwidth: 930 Hz/pixel. The voxel size was 1.32 × 1.32 × 7 mm3. Cine images were acquired in the 
three-chamber, horizontal long-axis, and vertical long-axis planes.
In the STEMI group, late gadolinium enhancement (LGE) images covering the entire left ventricle were 
acquired 10–15 minutes after an intravenous injection of 0.15 mmol/kg of gadoterate meglumine (Gd2 + -DOTA, 
Dotarem, Guebert S.A.) using segmented phase-sensitive inversion recovery (PSIR) turbo fast low-angle shot 
sequence. Typical LGE imaging parameters were matrix = 192 × 256, flip angle = 25°, TE = 3.36 ms, band-
width = 130 Hz/pixel, echo spacing = 8.7 ms and trigger pulse = 2. The voxel size was 1.32 × 1.32 × 8 mm3. 
Inversion times were individually adjusted to optimize nulling of apparently normal myocardium (typical values, 
200 to 300 ms).
Left ventricular outcomes were assessed at 6 months using the same CMR protocol. We assessed change in 
LVEF (%) at six months from baseline after the acute STEMI and global longitudiual systolic strain at six months. 
Diogenes feature-tracking software (TomTec Imaging Systems, Germany) was used to quantify systolic strain 
from long axis cine images (horizontal, vertical long axis and left ventricular outflow tract cine images) in related 
to end-diastole, then these three longitudinal systolic strains were averaged to derive global longitudinal strain 
(GLS).
Mathematical modelling of the left ventricle. Left ventricular geometries were reconstructed from in 
vivo cine CMR images in early diastole when left ventricular pressure is lowest, as shown in Fig. 6. In the STEMI 
group, short-/long- axial views of LGE images (Fig. 6D and E) were combined with cine images to define MI 
regions in the three-dimensional left ventricular models (Fig. 6F). Details of the computational heart model con-
struction have been previously described18.
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Left ventricular dynamics at end-diastole and end-systole were solved using an in-house developed IB/FE 
method51, which employs a finite element description of the myocardial mechanics that enables the use of realistic 
constitutive models. The formulation of the IB/FE approach and application in left ventricular dynamics can be 
found in refs18,21.
The total myocardial stress was defined as
 µσ
σ
= − + ∇ + ∇ +




p u u[ ( ) ] myocardium
0 blood region
,
(1)
T
s
where p is the blood pressure, µ is the blood viscosity, u is the fluid velocity, I is the identity matrix, and σs is the 
elastic myocardial stress, which was described as the sum of the passive stress (σ p) and the active stress (σa). σ p 
was determined using a strain energy function W18,
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T
1  is the 
first strain invariant,  is the structural deformation gradient. The left ventricular myofibre architecture was 
described in terms of the myofiber direction f0 and the sheet axis s0, defined in the reference configuration. Based 
on these material axes, the following strain invariants were introduced as
= ⋅ = ⋅ = ⋅I I If f s s f s(C ), (C ), (C ), (3)4f 0 0 4s 0 0 8fs 0 0
Assuming the fibre can only bear the loading when it is stretched, the terms involving I4f  and I4s are non-zero 
only if >I 1i4 , then in the adopted IB/FE approach, the passive structural stress tensor (σ
p) was defined as



β
σ = ∂
∂
−−
W
J
Jdet( ) log( ),
(4)
p T s1 2
where det() is the determination of the deformation gradient, βs is a constant to further enforce the incompressi-
bility of the, and =J det( ).
The active stress σa was defined as
σ = ⊗ = ⊗+T T Tf f f f(time, Ca , SL, ) (5)a 2 req
Figure 6. An example of the left ventricular model construction for a healthy control: (A), Left ventricular 
boundary segmentation; (B), reconstructed left ventricular geometry. An example of a diseased left ventricular 
model construction: (C), left ventricular boundary segmentation; (D), a LGE image in a middle short-axial 
position, MI region is indicated by the arrows, the black region inside the infarct region represents the 
microvascular obstruction. (E), a LGE image in a long-axial view; (F), reconstructed left ventricular model, 
the infart region is represented by the red colour, and the remote viable myocardium is represented by the blue 
color. A linear transition region is defined from the infart region towards the remote viable myocardium within 
10 mm (1: 100% infarction, 0: viable myocardium).
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where T  is the myocardial active tension, modelled by a group of ordinary differential equations of time, intracel-
lular calcium concentration ( +Ca2 ), sarcomere length (SL), and the active tension T req when the stretch of sarco-
mere is 1 (the so-called required contractility), f is the myofibre orientation at current configuration. T req reflects 
the overall left ventricular contractility associated with the measured left ventricular pump function at the time of 
the CMR scan, but does not represent the maximum myocardial contractility which should be the contractility 
when myocardium is under maximum activation, for example under stressed CMR imaging. The difference 
between T req and the maximum capacity of myocardial contractility would indicate the contractile reserve, which 
reflects how much myocardium can further increases its contractile function when needed.
A detailed description of the active tension model has been previously described in a prior study18. In brief, the 
contractile force T in Eq.(5) was modelled by cross-bridge cycling between the thin filaments and thick filaments, 
and calculated from a fading memory model52
∑
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where z is the fraction of actin binding sites, zmax is the maximum fraction of actin binding sites available at a 
given stretch λ f , β0 is a constant, α is a measure of the curvature of the force-velocity relation, =Q i( 1, 2, 3)i  were 
determined by
λ
α= −
dQ
dt
A
d
dt
Q , (7)
i
i
f
i i
where Ai and αi are constant parameters.
Boundary Conditions. The longitudinal displacement of the left ventricular base and the circumferential 
displacement of the basal plane were set to zero values. A pressure loading condition consistent with end-diastole 
was applied to the endocardial wall and the pressure consistent with systole was then rapidly ramped up. At the 
same time, a prescribed intracellular calcium transient was applied to the myocardium to induce active tension 
generation, which remained constant when the maximum value was attained. Because invasive left ventricu-
lar pressure measurements were not technically feasible at the time of the CMR scan in our hospital, a typical 
end-diastolic pressure of 8 mmHg was assigned to the hyper-control group and an elevated value of 16 mmHg was 
adopted for the STEMI group as in our prior study18. The peak systolic blood pressure was approximated from the 
brachial arm-cuff BP measurements. A detailed description of the IB/FE left ventricular model implementation 
can be found in ref.18.
Model personalization. To personalize the left ventricular models, material parameters were determined 
by minimizing the difference between the simulated left ventricular dynamics and in vivo CMR measurements, 
including a b a b a b a b, , , , , , ,f f s s fs fs in Eq. (2) for myocardial passive property and T
req in active tension genera-
tion (Eq. (5)), other active tension parameters were kept the same as in ref.18 Specifically, passive myocardial 
parameters (a b a b a b a b, , , , , , ,f f s s fs fs) in healthy hearts were inversely determined by matching the simulated left 
ventricular dynamics in diastole to the measured in vivo data (left ventricular cavity volume and regional circum-
ferential strain estimated from cine images in related to end-diastole), the same approach as in our prior study24. 
To estimate T req in healthy hearts, the left ventricular model was firstly inflated to the end-diastolic pressure with 
optimized passive parameters, then followed by the systolic contraction. T req was determined by minimizing an 
objective function defined asin which ε ′i  is the segmental systolic circumferential strain estimated from cine 
images using an in-house developed b-spline methods25,27, εi is the corresponding strain from the simulated left 
ventricular model, N is the total number of the segments from short-axis images, ′V  is the measured left ventricu-
lar cavity volume from CMR images, V  is the simulated value.
ε ε
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In the MI models, we assumed that the passive response of the infarct zone was 50 times stiffer than hypo- or 
akinetic myocardium which did not exhibit late gadolinium enhancement (i.e. potentially viable myocardium), as 
previously described17,31. The passive response for myocardium remote from the infarct zone, i.e. remote zone 
myocardium, was determined using a similar approach as used in the healthy left ventricular models. In systole, 
the infarct zone was modelled as a purely passive material, and T req in remote zone was determined by matching 
the measured end-systolic circumferential strain data
ε ε
=
∑ − ′=
N
Obj
( )
,
(9)
i
N
i iMI 1
2
un
un
where Nun is the number of segmental remote regions. The average value of Nun is ±13 3. Note that the 
end-systolic volume and the strain (contractility) in the infarct zone were not used because of the purely passive 
response assumption of the MI region. Previous studies have shown that the uncertainty from estimates of passive 
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stiffness arising from the population-based end-diastolic pressure has less effect on the contractility (T req) estima-
tion19. Therefore, our estimates of left ventricular contractility may be more robust than the estimates of passive 
myocardial stiffness.
Statistical Analysis. Given the unknown validity of the biomechanical parameters, we adopted an extreme 
case-control design46, and because of the computational complexity of modelling left ventricular biomechanics, the 
sample size was necessarily limited in order to be computationally efficient. Based on the study from Wang 
et al.30, the mean difference in the average required myocardial contractility (T req) between the normal group and 
the left ventricular remodelled group was 72 kPa, and the square root of the average of the two standard deviations 
was 36 kPa. On the assumption of independent additive normal noise, a sample size calculation for a paired compar-
ison of T req using a two-sided t-test indicated that 6 subjects with complete data would confer 88% power at a signif-
icance level 0.05. The sample size calculation was performed with R statistical software. This sample size is similar to 
one other study using computational left ventricular modelling29.
Data distribution and normality was assessed using the Kolmogorov-Smirnov test, and data with a normal 
distribution were expressed as means together with standard deviation. Differences between the groups were 
assessed using two-sample t-test. Linear correlations were assessed using Person’s correlation. The statistical 
analyses were performed using MATLAB (Mathworks, MA, US) and a p-value ≤ 0.05 was taken as statistically 
significant.
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